United Therapeutics Corporation shares owned by UBS Group
Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in United Therapeutics Corporation
Tip: Access up to 7 years of quarterly data
All positions including United Therapeutics Corporation held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in United Therapeutics Corporation by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $18M | 80k | 229.72 |
| 2023-12-31 | $14M | 65k | 219.90 |
| 2023-09-30 | $13M | 58k | 225.87 |
| 2023-06-30 | $13M | 60k | 221.00 |
| 2023-03-31 | $15M | 67k | 223.96 |
| 2022-12-31 | $15M | 55k | 278.09 |
| 2022-09-30 | $8.8M | 42k | 208.20 |
| 2022-06-30 | $16M | 68k | 235.64 |
| 2022-03-31 | $9.6M | 54k | 178.71 |
| 2021-12-31 | $18M | 85k | 215.90 |
| 2021-09-30 | $8.4M | 46k | 184.92 |
| 2021-06-30 | $20M | 111k | 179.27 |
| 2021-03-31 | $7.1M | 43k | 167.27 |
| 2020-12-31 | $3.0M | 20k | 150.98 |
| 2020-09-30 | $5.8M | 58k | 100.00 |
| 2020-06-30 | $4.8M | 39k | 120.96 |
| 2020-03-31 | $106k | 1.1k | 95.17 |
| 2019-12-31 | $220k | 2.5k | 87.53 |
| 2019-09-30 | $4.6M | 57k | 79.75 |
| 2019-06-30 | $421k | 5.4k | 77.94 |
| 2019-03-31 | $11M | 89k | 117.40 |
| 2018-12-31 | $12M | 112k | 109.28 |
| 2018-09-30 | $2.2M | 18k | 127.84 |
| 2018-06-30 | $2.8M | 24k | 113.40 |
| 2018-03-31 | $6.5M | 58k | 112.37 |
| 2017-12-31 | $1.1M | 7.1k | 148.45 |
| 2017-09-30 | $2.2M | 19k | 117.22 |
| 2017-06-30 | $2.6M | 20k | 129.70 |
| 2017-03-31 | $4.0M | 29k | 135.36 |
| 2016-12-31 | $6.9M | 48k | 143.44 |
| 2016-09-30 | $5.6M | 48k | 118.09 |
| 2016-06-30 | $2.2M | 21k | 105.87 |
| 2016-03-31 | $3.4M | 30k | 111.55 |
| 2015-12-31 | $9.3M | 60k | 156.62 |
| 2015-09-30 | $5.5M | 42k | 131.35 |
| 2015-03-31 | $6.9M | 40k | 172.22 |
Top funds holding United Therapeutics Corporation
View all funds holding United Therapeutics Corporation